Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 6/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.64 |
| ▸ | PDPK1 | O15530 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.64 |
| ▸ | CYTH3 | O43739 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17897765 | 0.95 | AKT1 (0.91) | AKT1ALDH1A1PDPK1CYP1A2CYTH3 | |
| SCHEMBL15777715 | 0.89 | AKT1 (0.80) | AKT1ALDH1A1PDPK1CYP1A2CYTH3 | |
| SCHEMBL17897762 | 0.88 | AKT1 (0.79) | AKT1ALDH1A1PDPK1CYP1A2CYTH3 | |
| SCHEMBL15777263 | 0.85 | AKT1 (0.74) | AKT1ALDH1A1PDPK1CYP1A2CYTH3 | |
| SCHEMBL17897763 | 0.85 | AKT1 (0.74) | AKT1ALDH1A1PDPK1CYP1A2CYTH3 | |
| SCHEMBL15788804 | 0.85 | AKT1 (0.73) | AKT1ALDH1A1PDPK1CYP1A2KMT2A | |
| SCHEMBL15776744 | 0.85 | AKT1 (0.73) | AKT1ALDH1A1CYP1A2KMT2AMEN1 | |
| SCHEMBL15777497 | 0.84 | AKT1 (0.73) | AKT1ALDH1A1PDPK1CYTH3KMT2A | |
| SCHEMBL17897751 | 0.83 | AKT1 (0.71) | AKT1ALDH1A1PDPK1CYP1A2CYTH3 | |
| SCHEMBL17897768 | 0.82 | AKT1 (0.80) | AKT1ALDH1A1PDPK1CYP1A2CYTH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160194279-A1 | ONE POT PROCESS FOR THE CONVERSION OF AROYL CHLORIDES TO ACYL THIOUREAS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-07-07 | — | — | US | claimed |
| US-20160194279-A1 | ONE POT PROCESS FOR THE CONVERSION OF AROYL CHLORIDES TO ACYL THIOUREAS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-07-07 | — | — | US | disclosed |
| US-20160194279-A1 | ONE POT PROCESS FOR THE CONVERSION OF AROYL CHLORIDES TO ACYL THIOUREAS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-07-07 | — | — | US | disclosed |
| US-20160194279-A1 | ONE POT PROCESS FOR THE CONVERSION OF AROYL CHLORIDES TO ACYL THIOUREAS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-07-07 | — | — | US | disclosed |
| US-9040585-B2 | Small molecule antagonists of phosphatidylinositol-3,4,5-triphosphate (PIP3) and uses thereof | TUFTS UNIVERSITY (US) | 2015-05-26 | — | — | US | disclosed |
| US-20140187639-A1 | Small Molecule Antagonists of Phosphatidylinositol-3,4,5-Triphosphate (PIP3) and Uses Thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2014-07-03 | — | — | US | disclosed |
| WO-2014087431-A1 | ONE POT PROCESS FOR THE CONVERSION OF AROYL CHLORIDES TO ACYL THIOUREAS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-06-12 | — | — | WO | disclosed |
| US-8628961-B2 | Small molecule antagonists of phosphatidylinositol-3,4,5-triphosphate (PIP3) and uses thereof | TUFTS UNIVERSITY (US) | 2014-01-14 | — | — | US | disclosed |
| US-20120016033-A1 | Small Molecule Antagonists of Phosphatidylinositol-3,4,5-Triphosphate (PIP3) and Uses Thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120016033-A1 | Small Molecule Antagonists of Phosphatidylinositol-3,4,5-Triphosphate (PIP3) and Uses Thereof | PIP5K1A, PIP5K1B, PIP4K2A | AKT1 68/4885ALDH1A1 4808/4885PDPK1 61/4885 |
| US-20160194279-A1 | ONE POT PROCESS FOR THE CONVERSION OF AROYL CHLORIDES TO ACYL THIOUREAS | TRRAP, NAT1, AHR | AKT1 2603/4885ALDH1A1 445/4885PDPK1 4430/4885 |
| US-20140187639-A1 | Small Molecule Antagonists of Phosphatidylinositol-3,4,5-Triphosphate (PIP3) and Uses Thereof | PIP5K1A, PIP5K1B, PIP4K2A | AKT1 68/4885ALDH1A1 4808/4885PDPK1 61/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.